Drawing for IMOTOPE

USPTO serial 79208547

IMOTOPE

Reviewed by CopyMark Law Group

Reg. 5348342Status 709
Filing date
Status date
Registration date
Dec 5, 2017
Examiner
LEIPZIG, MARC J
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IMOTOPE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Martin W. Schiffmiller

Martin W. Schiffmiller Kirschstein Israel Schiffmiller & Pieroni, P.C.425 Fifth Avenue, 5th Floor, Suite 501New York, NY 10016-2223UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products for use in the treatment and prevention of autoimmune diseases, infectious diseases, cancer, multiple sclerosis, type 1 diabetes, myasthenia gravis, rheumatoid arthritis and viral diseases, allergies, celiac disease and immune responses against allofactors used for therapy, viral vectors used for gene therapy or gene vaccination and autoimmune responses to organ or cellular transplantation; veterinary preparations for mammals for use in the treatment and prevention of autoimmune diseases, infectious diseases and cancer; vaccines; vaccine preparations for human or veterinary useSECTION 71 - CANCELLED—
042Scientific and technological services, namely, scientific research, analysis and design in the fields of immunology, chronic diseases, infectious diseases, cancer and regeneration of damaged organs; industrial research and analysis in the fields of immunology, chronic diseases, infectious diseases, cancer and regeneration of damaged organs; research and development of vaccines and medicinesSECTION 71 - CANCELLED—
044Medical services; veterinary services; hygienic and beauty care for human beings and animals; providing medical information concerning vaccinationSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 5, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 30, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 19, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Mar 29, 2025INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Mar 29, 2025INPCINVALIDATION PROCESSED—
Feb 21, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jun 21, 2024C71TCANCELLED SECTION 71—
Dec 5, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 12, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 20, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 20, 2018FIMPFINAL DISPOSITION PROCESSED—
Mar 5, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 5, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 19, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 19, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 30, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 14, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 14, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 14, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 14, 2017ALIEASSIGNED TO LIE—
Jul 20, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 20, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 20, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 1, 2017RFNTREFUSAL PROCESSED BY IB—
Jun 15, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 14, 2017RFRRREFUSAL PROCESSED BY MPU—
Jun 6, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 2, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 1, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 31, 2017DOCKASSIGNED TO EXAMINER—
May 31, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 25, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance